Canaccord Maintains Buy, $43 Tgt On Boston Scientific As Firm Would Buy Stock Ahead Of Near-Term Events Like The HRS Meeting In May, Digestive Disease Week Update In Mid May, EuroPCR In Late May, Close Of BTG Acquisition In Mid '19, Analyst Day In June
Benzinga_Newsdesk